EFM
CRL icon

E Fund Management’s Charles River Laboratories CRL Stock Holding History

E Fund Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Sell
1,734
-272
-14% -$48.4K 0.01% 330
2026
Q1 		$346K Buy
+2,006
New +$372K 0.01% 357
2025
Q2 		$284K Buy
1,874
+21
+1% +$2.8K 0.01% 315
2025
Q1 		$279K Buy
1,853
+33
+2% +$5.53K 0.01% 324
2024
Q4 		$336K Buy
+1,820
New +$351K 0.02% 294
2024
Q2 		– Sell
-739
Closed -$200K – 335
2024
Q1 		$200K Buy
+739
New +$176K 0.01% 349

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

E Fund Management's CRL Position: Q2 2026 in Review

E Fund Management reduced its Charles River Laboratories (CRL) stake by 14% in Q2 2026, selling an estimated $48.4K and leaving 1,734 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #330.

E Fund Management first reported a position in CRL in Q1 2024 and has held it in 6 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • E Fund Management held 1,734 shares of Charles River Laboratories worth $393K as of Q2 2026.
  • E Fund Management sold 272 Charles River Laboratories shares in Q2 2026, an estimated $48.4K.
  • Charles River Laboratories made up 0.01% of E Fund Management's portfolio in Q2 2026, its #330 holding.
  • E Fund Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 6 quarters since.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.